Argent BioPharma Ltd is a clinical-stage, revenue-generating biopharmaceutical company listed on the London Stock Exchange, dedicated to enhancing accessible medical treatments through innovative advancements in poly pharmacology and nanotechnology. With a robust focus on addressing unmet medical needs, Argent BioPharma is committed to cutting-edge research and development in the pharmaceutical industry.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Active Pharmaceutical Ingredients (APIs)
– Contract Manufacturing Organization (CMO) services for non-sterile oral liquid dosage forms
– Fully automated production in a GMP certified facility

Argent BioPharma Ltd continues to make strides in the biopharmaceutical sector, ensuring high-quality manufacturing and development for its clients. For more information, please visit argentbiopharma.com.